Oncology Drugs Market Share, Trends, Size, Research and Forecast 2019-2025

There is a significant rise in the incidence and mortality of cancer globally. According to the WHO, the global cancer burden is estimated to have risen to around 18.1 million new cases with around 9.5 million mortality in 2018. Cancer is the second leading cause of mortality across the globe. The main cause of cancer includes high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, and alcohol use. Tobacco causes more than 22% of cancer casualties globally. The burden of cancer can be reduced by performing early detection of cancer and the management of patients who develop cancer, which may include proper and effective medication. Thereby, surge in the number of cancer patients is likely to drive the global oncology drugs market.

A full report of Global Oncology Drugs Market is available at: https://www.omrglobal.com/industry-reports/oncology-drugs-market

Growing adoption of personalized medicine is augmenting the oncology drugs market
The increasing adoption of personalized medicines for cancer treatment is furthermore augmenting the growth of the oncology drugs market. Personalized medicine has the potential to modify therapy with the best response and highest safety margin to ensure better patient care. Personalized medicine holds promise for improving healthcare while lowering costs by enabling each patient to receive earlier diagnoses, optimal treatments, and risk assessments, expected to be a positive indicator for oncology drugs market growth. There is a diversity of personalized medicines in development.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/oncology-drugs-market

Around 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Biopharmaceutical companies nearly doubled their R&D investment in personalized medicines over the past five years and expect to increase their investment in the future. Moreover, estimates of disease susceptibility or disease prognosis can be improved by combining test results with knowledge about various factors such as age, lifestyle, or Tumor size. This is promising for predicting disease susceptibility, disease prognosis, or drug response of an individual patient.

Current Market Trends Covered in the Global Oncology Drugs Market Report

o Based on the drug class type, the immunotherapy segment is estimated to hold a significant market share during the forecast period.
o Based on the geography, North America is estimated to dominate the global oncology drugs market during the forecast period.
o Asia-Pacific is anticipated to register the fastest growth in the global oncology drugs industry during the forecast period.

Global Oncology Drugs Market Segmentation

By Drug Class Type

o Chemotherapy
o Targeted Therapy
o Immunotherapy
o Hormonal Therapy

By Indication

o Lung Cancer
o Colorectal Cancer
o Prostate Cancer
o Bladder Cancer
o Liver Cancer
o Others (Stomach Cancer, Kidney Cancer, and so on)

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/oncology-drugs-market

Global Oncology Drugs Market - Segment by Region

North America

o United States
o Canada

Europe

o Germany
o United Kingdom
o France
o Spain
o Italy
o Rest of Europe

Asia-Pacific

o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World

o Middle East & Africa
o Latin America

Company Profiles

o AbbVie Inc.
o Amgen Inc.
o Astellas Pharma Inc.
o AstraZeneca PLC
o Bayer AG
o Bristol-Myers Squibb Co.
o Celgene Corp.
o Eli Lilly and Co.
o Exelixis, Inc.
o F. Hoffmann-La Roche Ltd.
o Johnson & Johnson Services Inc.
o Merck & Co., Inc.,
o Novartis AG,
o Pfizer Inc.
o Sanofi SA

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.